￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Must-read for patients: An overview of the basic information in the Chinese instructions for sotorasibu (AMG510)

2026-02-01 22:25:32

Check Details
As a targeted drug, sotoracib (AMG510), what is its pricing and latest sales trends on the market?

2026-02-01 22:25:32

Check Details
How effective is Sotoracib (AMG510) in advanced cancer?

2026-02-01 22:25:32

Check Details
Anti-cancer information: Dosage of sotoraxib (AMG510) and a brief understanding of its usage

2026-02-01 22:25:32

Check Details
Sotoracib (AMG510): a new anti-cancer drug developed by the American company Amgen

2026-02-01 22:25:32

Check Details
Instructions for use of Sotoracib (AMG510)

2026-02-01 22:25:32

Check Details
Sotoracib (AMG510) market pricing and global sales trends

2026-02-01 22:25:32

Check Details
Therapeutic potential of sotoracib (AMG510) in advanced cancer

2026-02-01 22:25:32

Check Details
Medication Guide and Dosage Analysis for Sotorasib (AMG510)

2026-02-01 22:25:32

Check Details
What is the price of the Indian version of the targeted drug Sotorasibu (AMG510)?

2026-02-01 22:25:32

Check Details
When will sotoraxibu (AMG510) be available in China?

2026-02-01 22:25:32

Check Details
Prospects for the listing of Sotoracib (AMG510) in China

2026-02-01 22:25:32

Check Details
Category
相关知识